Education
About Us
Working with TipRanks
Follow Us
Cipher Pharmaceuticals Inc (TSE:CPH)
:CPH
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.21Last Year’s EPS
0.29Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 18, 2025
|% Change Since: 4.92%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Positive
The earnings call reveals significant revenue and market share growth, particularly from Epuris and the newly integrated Natroba business. Despite these achievements, challenges such as declining licensing revenue and increased SG&A expenses were notable. The positive revenue growth and strategic business developments outweigh the lowlights, suggesting an optimistic outlook.Company Guidance
During the conference call, Cipher Pharmaceuticals provided guidance for the fiscal year and fourth quarter of 2024, highlighting several key financial metrics and strategic initiatives. The company's total net revenue for Q4 2024 increased by 141% compared to the same quarter the previous year, reaching $11.8 million, driven by $10.5 million in product revenue, which rose by 209%. This increase was largely attributed to $6.5 million in revenue from the newly acquired Natroba business. For the full year of 2024, total net revenue was $33.4 million, a 58% increase from 2023, with product revenue contributing $26.7 million, up by 111%. Licensing revenue, however, decreased by 22% to $6.6 million due to competitive pressures and contractual changes. The acquisition of Natroba also bolstered gross margins, which improved to 77% in Q4, excluding non-cash adjustments. The company generated $8.3 million in cash during Q4 2024, ending the year with $17.8 million in cash on hand. Looking ahead, Cipher aims to expand its market presence, particularly in the U.S. scabies market, and is actively pursuing in-licensing and acquisition opportunities to enhance its dermatology and infectious diseases portfolio.Significant Revenue Growth in Q4 2024
Total net revenue for the fourth quarter of 2024 was $11.8 million, an increase of $6.9 million or 141% compared to the same quarter in the prior year, driven by increased product revenue.
Epuris Market Share Growth
Product revenue from Epuris in Canada was $3.5 million for Q4 2024, an increase of 21% compared to the prior year. Market share for Epuris increased by 2.7% to 47.7% at the end of 2024.
Successful Integration of Natroba Business
The Natroba business contributed $6.5 million in revenue for Q4 2024, with a gross margin of 81%. The transition to direct commercialization was completed at the end of 2024.
Strong Cash Flow Generation
Cipher's business generated $8.3 million in cash during Q4 2024, ending the quarter with $17.8 million in cash on hand.
Increased Gross Margin
Gross margin on product revenue increased by 5% to 77% in Q4 2024, excluding non-cash fair value adjustments.
---
TSE:CPH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:CPH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 18, 2025 | C$11.98 | C$13.45 | +12.27% |
| Nov 07, 2024 | C$15.54 | C$13.88 | -10.68% |
| Aug 08, 2024 | C$13.81 | C$14.43 | +4.49% |
| May 09, 2024 | C$8.95 | C$9.25 | +3.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cipher Pharmaceuticals Inc (TSE:CPH) report earnings?
Cipher Pharmaceuticals Inc (TSE:CPH) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Cipher Pharmaceuticals Inc (TSE:CPH) earnings time?
Cipher Pharmaceuticals Inc (TSE:CPH) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CPH EPS forecast?
TSE:CPH EPS forecast for the fiscal quarter 2025 (Q1) is 0.21.
---